The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Kochergin N.G.

I.M. Sechenov Moscow Medical Academy

Psoriasis: Compliance and calcipotriol + betamethazone dipropionate

Authors:

Kochergin N.G.

More about the authors

Journal: Russian Journal of Clinical Dermatology and Venereology. 2010;8(3): 42‑46

Views: 1376

Downloaded: 21

Download PDF (RU)
Contact the author
Table of contents

To cite this article:

Kochergin NG. Psoriasis: Compliance and calcipotriol + betamethazone dipropionate. Russian Journal of Clinical Dermatology and Venereology. 2010;8(3):42‑46. (In Russ.)

 
МСФ на ЯМ
Close metadata
Recommended articles:
The role of tele­medicine in dermatology with examples on the orga­nization of services for patients with psoriasis and acne. Russian Journal of Clinical Dermatology and Vene­reology. 2024;(2):111-117
The use of systemic cyto­protective therapy in asso­ciation with combination topi­cal therapy on the basis of sali­cylic acid and glucocorticosteroids in psoriasis vulgaris. Russian Journal of Clinical Dermatology and Vene­reology. 2024;(2):168-172
Psoriasis exudativa in patient with here­ditary hemo­rrhagic tela­ngiectasia. Russian Journal of Clinical Dermatology and Vene­reology. 2024;(4):356-361
Psoriasis in pregnant women. Russian Journal of Clinical Dermatology and Vene­reology. 2024;(5):517-524
New aspe­cts of psoriasis pathogenesis: meta­bolomic profiling in dermatology. Russian Journal of Clinical Dermatology and Vene­reology. 2024;(5):526-531
Study of the effe­ctiveness of different methods of exte­rnal psoriasis therapy in a new expe­rimental model of chro­nic inflammation. Russian Journal of Clinical Dermatology and Vene­reology. 2024;(5):552-557
Psoriasis: analysis of como­rbid pathology. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(1):16-21
Morbidity of Psoriasis and psoriatic arthritis in the Repu­blic of Bashkortostan in 2012—2022. Russian Journal of Preventive Medi­cine. 2024;(7):38-45

Keywords:

psoriasis
external therapy
daivobet

Authors:

Kochergin N.G.

I.M. Sechenov Moscow Medical Academy

List of references:

  1. Horn E. NPF USA 2007.
  2. Winterfield L.S. et al. Psoriasis treatment: current and emerging directed therapies. Ann Reum Dis 2005; 64 (Suppl II): 87-90.
  3. Feldman S.R. et al. Psoriasis: improving adherence to topical therapy. J Am Acad Dermatol 2008; 59: 6: 1009-1016.
  4. Brown K., Rehmus W., Kimball A. J Am Acad Dermatol 2006; 55: 607-613.
  5. Ruzicka T., Lorenz B. Comparison of calcipotriol monotherapy and a combination of calcipotriol and betamethasone valerate after 2 weeks' treatment with calcipotriol in the topical therapy of psoriasis vulgaris: a multicentre, double-blind, randomized study. Br J Dermatol 1998; 138: 254-258.
  6. Kaufmann R. et al. A new calcipotriol/betamethasone dipropionate formulation (Daivobet) is an effective once-daily treatment for psoriasis vulgaris.Dermatology 2002; 205: 389-393.
  7. Kragballe K. et al. Efficacy of once-daily treatment regimens with calcipotriol/betamethasone dipropionate ointment and calcipotriol ointment in psoriasis vulgaris. Br J Dermatol 2006; 155: 737-741.
  8. Filimonkova N.N. i dr. Klinicheskii effekt posledovatel'nogo naznacheniya preparatov daivobet i daivoneks v kompleksnoi terapii bol'nykh psoriazom. Vestn dermatol venerol 2006; 6: 35-41.
  9. Korotkii N.G. i dr. Daivobet - novyi vysokoeffektivnyi preparat dlya naruzhnogo lecheniya bol'nykh srednetyazhelym i tyazhelym vul'garnym psoriazom. Klin dermatol venerol 2007; 4: 64-69.
  10. Monakhov K.N. i dr. Sovremennye aspekty naruzhnoi terapii psoriaza. Klin dermatol venerol 2006; 2: 47-50.
  11. Togoeva L.Sh. i dr. Naruzhnaya terapiya ogranichennykh form psoriaza. Klin dermatol venerol 2008; 2: 42-44.
  12. Katsambas A. et al. Improvement in quality of life in patients treated with adalimumab plus adjunctive topical therapy (calcipotriol/betamethasone) for moderate to severe psoriasis: Results of the BELIEVE study. 18th EADV Congress 2009; 1169.
  13. Thaci D., Ortonne J.P., Chimenti S. et al. A Phase IIIb, Multi-Centre, Randomized, Double-Blind, Vehicle-Controlled Study of the Efficacy and Safety of Adalimumab With and Without Calcipotriol/Betamethasone Topical Treatment in Patients with Moderate to Severe Psoriasis: The BELIEVE Study. Br J Dermatol 2010 Apr 2. [Epub ahead of print].

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.